Lonza | LONN - Cost Of Sales


Lonza reported CHF2.28B in Cost of Sales for its fiscal semester ending in June of 2025.





Cost Of Sales Change Date
Akzo Nobel EUR 1.41B 28M Mar/2026
Alcon AG USD 1.18B 26M Mar/2026
Almirall EUR 191.5M 2.29M Dec/2025
AstraZeneca USD -204M 3.48B Mar/2026
BASF EUR 11.87B 941M Mar/2026
Bayer EUR 5.23B 731M Mar/2026
Beiersdorf EUR 2.06B 50M Dec/2025
Covestro EUR 2.7B 5.39B Dec/2025
Demant DKK 2.89B 188M Dec/2025
Fresenius EUR 4.45B 262M Dec/2025
Fresenius Medical Care EUR 3.43B 248M Mar/2026
Geberit CHF 229.8M 22.8M Dec/2025
Genmab DKK 81M 23M Dec/2025
Givaudan CHF 2.07B 105M Dec/2025
GlaxoSmithKline GBP 1.88B 736M Mar/2026
GN Store Nord DKK 1.16B 1.08B Mar/2026
Hikma Pharmaceutical USD 959M 492.5M Dec/2025
Johnson Matthey GBP 6.9B 1.86B Jun/2026
Merck EUR 2.07B 219M Mar/2026
Novartis USD 3.46B 83M Mar/2026
Philips EUR 2.14B 669M Mar/2026
Roche Holding CHF 8.48B 4.61B Dec/2025
Sanofi EUR 3.67B 621M Mar/2026
Sika AG CHF 2.77B 49.8M Dec/2025
Smith & Nephew USD 870M 17M Dec/2025
Solvay EUR 876M 16M Mar/2026
UCB EUR 1.07B 146M Dec/2025